As we try to emerge from COVID-19, it’s a new age in compliance. And it’s more important than ever.
As one of the first compliance officers in the industry, Steve Vincze has partnered with Advantage and Forbes Books to share his expertise in the industry. More than ever people are using digital platforms to meet, educate and sell. Europe has led the way in new privacy regulations and, in the U.S., several states are passing and enforcing new privacy legislation while a new federal law has been introduced in Congress. With the current political climate pointing towards more caution and compliance, it’s now more important than ever that life science companies are aware of the ethical and compliance steps they need to take … and why.
For more than 25 years, Steve Vincze has partnered with leading healthcare and life science companies around the globe to help them develop practical, targeted and strategic compliance initiatives. An eminent commercial compliance authority in the life sciences, Steve was an active participant in the landmark 2001 TAP Pharmaceuticals case, one of the largest settlements in the pharmaceutical industry, which directly led to key reforms that changed commercial compliance practices and significantly impacted how pharmaceutical products are marketed and sold. Steve is one of the few experts still practicing who can share historical knowledge of these changes, and this book offers a thoughtful reference guide to the key compliance factors that every life sciences executive needs to understand and prepare for.
In addition to the insights from key cases that have shaped the compliance landscape, Steve offers practical, step-by-step recommendations that executives and compliance officers can use to ensure that their organizations are protected and positioned for optimal growth. Whether you are seeking investors or preparing to roll out a new product, this book will offer solutions and support to anticipate challenges and help ensure that compliance becomes your competitive advantage.
Steve understands that building an effective and efficient compliance initiative can be a challenge for life science executives and entrepreneurs. In this book, he shares insights and expertise to help readers create a compliance framework that will anticipate and minimize potential areas of risk and position their organization for optimal commercial success.
In clear, accessible language, Steve first explains the key laws and governmental guidance every life science executive needs to know using case studies from his career. Next, he details the five-step process organizations should follow to ensure commercial compliance success, an innovative process that he has successfully implemented with countless life science organizations, and shares strategic insights that will equip readers to prepare for “what’s next.”